Edap Tms (NASDAQ:EDAP) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

EDAP has been the topic of several other research reports. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. Piper Sandler dropped their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday, March 28th. Finally, HC Wainwright reiterated a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research note on Friday, March 28th.

Edap Tms Stock Performance

Shares of EDAP opened at $2.16 on Thursday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. The stock has a market capitalization of $80.14 million, a price-to-earnings ratio of -3.32 and a beta of 0.13. Edap Tms has a 52-week low of $1.26 and a 52-week high of $7.08. The stock’s 50-day simple moving average is $1.95 and its 200 day simple moving average is $2.27.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Research analysts forecast that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Illumine Investment Management LLC purchased a new position in shares of Edap Tms during the 4th quarter valued at $50,000. Jane Street Group LLC lifted its holdings in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after buying an additional 25,650 shares during the last quarter. Millennium Management LLC grew its holdings in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after buying an additional 33,558 shares in the last quarter. Finally, Cetera Investment Advisers increased its stake in Edap Tms by 33.9% in the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock worth $147,000 after acquiring an additional 19,000 shares during the last quarter. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.